New drug candidate B-OT passes first human safety check
Knowledge-focused
Completed
This early-stage study tested a new drug called Benfo-Oxythiamine (B-OT) in 48 healthy male volunteers to see if it is safe and how the body processes it. Participants took the drug as capsules, either once or daily for a week, and were closely monitored in the clinic. The result…
Phase: PHASE1 • Sponsor: Benfovir AG • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:52 UTC